tiprankstipranks
Livzon Pharmaceutical Announces Indonesian Joint Venture
Company Announcements

Livzon Pharmaceutical Announces Indonesian Joint Venture

Livzon Pharmaceutical Group (HK:1513) has released an update.

Don't Miss our Black Friday Offers:

Livzon Pharmaceutical Group Inc. has announced the establishment of a joint venture in Indonesia with PT GLOBAL CHEMINDO MEGA TRADING, a subsidiary of the Indonesian listed company PT KALBE FARMA, TBK. The venture will focus on manufacturing active pharmaceutical ingredients with an initial capital investment totaling IDR 1,306,080,000,000. Livzon’s subsidiary LIANSGP HOLDING PTE. LTD. will hold an 80% stake while PT GLOBAL CHEMINDO MEGA TRADING will hold the remaining 20% stake.

For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical Reports Mixed Q3 2024 Financial Results
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical Proposes New Non-Executive Director
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical Group Plans Key Meeting for 2024
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App